A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Completed · Phase 3

Conditions studied: Diphtheria, Tetanus, Acellular Pertussis

In brief

This study will evaluate the safety and immune response to GlaxoSmithKline Tdap vaccine compared to licensed Td vaccine when used as a booster in healthy adolescents (10-18 years of age).

Key facts

Study ID

NCT00109330

Run by

GlaxoSmithKline

People needed

4116

Starts

2002-11-01

Expected to finish

2004-04-01

Last updated by the study team

2016-09-09

Who can join

Age: 10 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy adolescents with history of completed routine vaccination against diphtheria, tetanus, and pertussis (DTP).

You may not qualify if…

• Use of any other investigational drug or vaccine 30 days preceding study vaccination.
• Chronic administration of immunosuppressants.
• Administration of pre-school DTP vaccine within previous 5 years.
• Administration of Td booster within previous 10 years.

Where it is running

• GSK Investigational Site — Mesa, Arizona, United States
• GSK Investigational Site — Tempe, Arizona, United States
• GSK Investigational Site — Jonesboro, Arkansas, United States
• GSK Investigational Site — Little Rock, Arkansas, United States
• GSK Investigational Site — Escondido, California, United States
• GSK Investigational Site — Fullerton, California, United States
• GSK Investigational Site — Redondo Beach, California, United States
• GSK Investigational Site — Rolling Hills Est, California, United States
• GSK Investigational Site — Torrance, California, United States
• GSK Investigational Site — Yorba Linda, California, United States
• GSK Investigational Site — Boulder, Colorado, United States
• GSK Investigational Site — Centennial, Colorado, United States
• GSK Investigational Site — Golden, Colorado, United States
• GSK Investigational Site — Middletown, Connecticut, United States
• GSK Investigational Site — Norwich, Connecticut, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Bardstown, Kentucky, United States
• GSK Investigational Site — New Bedford, Maine, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — Milford, Massachusetts, United States
• GSK Investigational Site — Woburn, Massachusetts, United States
• GSK Investigational Site — Omaha, Nebraska, United States
• GSK Investigational Site — Whitehouse Station, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.